(2R,4aR,5S,8aR)-5-(2-(4-carboxyphenyl)prop-1-enyl)-7-methyl-2-((R)-6-methylhept-5-en-2-yl)-1,2,4a,5,8,8a-hexahydronaphthalene-4a-carboxylic acid

ID: ALA3339156

Chembl Id: CHEMBL3339156

PubChem CID: 102200701

Max Phase: Preclinical

Molecular Formula: C30H38O4

Molecular Weight: 462.63

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)=CCC[C@@H](C)[C@@H]1C=C[C@]2(C(=O)O)[C@@H](CC(C)=C[C@H]2/C=C(\C)c2ccc(C(=O)O)cc2)C1

Standard InChI:  InChI=1S/C30H38O4/c1-19(2)7-6-8-21(4)25-13-14-30(29(33)34)26(15-20(3)16-27(30)18-25)17-22(5)23-9-11-24(12-10-23)28(31)32/h7,9-15,17,21,25-27H,6,8,16,18H2,1-5H3,(H,31,32)(H,33,34)/b22-17+/t21-,25-,26+,27+,30-/m1/s1

Standard InChI Key:  YEQLBOWLDTXBBB-VVBJMDLTSA-N

Associated Targets(Human)

BCL2L1 Tchem Bcl-xL/BAK (60 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCL1 Tchem Induced myeloid leukemia cell differentiation protein Mcl-1/BH3-interacting domain death agonist (60 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 462.63Molecular Weight (Monoisotopic): 462.2770AlogP: 7.40#Rotatable Bonds: 8
Polar Surface Area: 74.60Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.95CX Basic pKa: CX LogP: 7.34CX LogD: 1.57
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.39Np Likeness Score: 2.05

References

1. Desrat S, Pujals A, Colas C, Dardenne J, Gény C, Favre L, Dumontet V, Iorga BI, Litaudon M, Raphaël M, Wiels J, Roussi F..  (2014)  Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.,  24  (21): [PMID:25266781] [10.1016/j.bmcl.2014.09.004]
2. Negi A, Murphy PV..  (2021)  Development of Mcl-1 inhibitors for cancer therapy.,  210  [PMID:33333396] [10.1016/j.ejmech.2020.113038]

Source